Persica Pharmaceuticals
  • Home
  • About Us
    • Our Story
    • Our Team
    • US Medical Advisors
    • UK & EU Medical Advisors
  • Therapeutic Focus
  • R&D
    • PP353
    • Clinical Trials
    • IP
    • Publications
  • News & Resources
    • News
    • Persica Resources
  • Contact Us
  • Home
  • About Us
    • Our Story
    • Our Team
    • US Medical Advisors
    • UK & EU Medical Advisors
  • Therapeutic Focus
  • R&D
    • PP353
    • Clinical Trials
    • IP
    • Publications
  • News & Resources
    • News
    • Persica Resources
  • Contact Us

Persica publications

Chronic low back pain, bacterial infection and treatment with antibiotics

Gilligan et al 2021

 

Intradiscal pharmacokinetics of oral antibiotics to treat Chronic Lower Back Pain

Czaplewski et al 2023

 

Modic changes as seen on MRI are associated with nonspecific chronic lower back pain and disability

Czaplewski et al 2023

 

Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration

Hagger et al 2024

 

Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study

Tripathi et al 2024

Footer Widget Area 1

Assign a widget to this area now.

Media Contact

ICR Healthcare
85 Gresham St,
London,
EC2V 7NQ
persica@icrhealthcare.com

Persica Pharmaceuticals Limited © 2024   |   Persica Phamaceuticals |   Privacy Notice